4.8 Article

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

Journal

SCIENCE
Volume 345, Issue 6204, Pages 1623-1627

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1255904

Keywords

-

Funding

  1. Intramural Research Program, NIH Clinical Center
  2. Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  3. National Cancer Institute [HHSN261200800001E]
  4. National Institute of Allergy and Infectious Diseases [5R01HL113304-01, AI071087, AI095848, AI061093]
  5. National Health and Medical Research Council of Australia
  6. Cancer Council NSW

Ask authors/readers for more resources

Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory receptor found on immune cells. The consequences of mutations in CTLA4 in humans are unknown. We identified germline heterozygous mutations in CTLA4 in subjects with severe immune dysregulation from four unrelated families. Whereas Ctla4 heterozygous mice have no obvious phenotype, human CTLA4 haploinsufficiency caused dysregulation of FoxP3(+) regulatory T (T-reg) cells, hyperactivation of effector T cells, and lymphocytic infiltration of target organs. Patients also exhibited progressive loss of circulating B cells, associated with an increase of predominantly autoreactive CD21(lo) B cells and accumulation of B cells in nonlymphoid organs. Inherited human CTLA4 haploinsufficiency demonstrates a critical quantitative role for CTLA-4 in governing T and B lymphocyte homeostasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available